|
ISRCTN
|
ISRCTN86294690
|
|
DOI
|
10.1186/ISRCTN86294690
|
|
ClinicalTrials.gov identifier
|
|
|
EudraCT number
|
|
|
Public title
|
A randomised trial of chemotherapy with or without granulocyte colony-stimulating factor (G-CSF) in operable osteosarcoma
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
BO06
|
|
Study hypothesis
|
To compare two regimens of chemotherapy using Doxorubicin and Cisplatin in operable osteosarcoma: one involving chemotherapy at three weekly intervals with surgery after two courses, the other, chemotherapy at two weekly intervals plus G-CSF with surgery after three courses.
|
|
Lay summary
|
http://www.ctu.mrc.ac.uk/research_areas/study_details.aspx?s=107
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Osteosarcoma
|
|
Participants - inclusion criteria
|
1. Untreated non-metastatic disease
2. Age less than or equal to 40 years
3. Neutrophils ≥1.5 times 10^9/l and platelets ≥100 times 10^9/l
4. Glomerular Filtration Rate (GFR) ≥60 ml/min/1.73 m^2
5. Serum bilirubin ≤ micromoles/L
6. Normal cardiac function
7. Informed consent
|
|
Participants - exclusion criteria
|
Not provided at time of registration
|
|
Anticipated start date
|
01/07/1993
|
|
Anticipated end date
|
30/09/2002
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
500
|
|
Interventions
|
Two regimens of chemotherapy:
1. The first is Doxorubicin and Cisplatin at three weekly intervals with surgery after two courses/chemotherapy.
2. The second is Doxorubicin and Cisplatin at two weekly intervals plus G-CSF with surgery after three courses.
|
|
Primary outcome measure(s)
|
1. Survival time
2. Response rate
3. Morbidity
4. Response duration
|
|
Secondary outcome measure(s)
|
Not provided at time of registration
|
|
Sources of funding
|
Medical Research Council (MRC) (UK)
|
|
Trial website
|
|
|
Publications
|
2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17227995
|
|
Contact name
|
Dr
Barbara
Uscinska
|
|
Address
|
MRC Clinical Trials Unit
222 Euston Road
|
|
City/town
|
London
|
|
Zip/Postcode
|
NW1 2DA
|
|
Country
|
United Kingdom
|
|
Email
|
|
|
Sponsor
|
Medical Research Council (MRC) (UK)
|
|
Address
|
20 Park Crescent
|
|
City/town
|
London
|
|
Zip/Postcode
|
W1B 1AL
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)20 7636 5422
|
|
Fax
|
+44 (0)20 7436 6179
|
|
Email
|
clinical.trial@headoffice.mrc.ac.uk
|
|
Sponsor website:
|
http://www.mrc.ac.uk
|
|
Date applied
|
28/02/2001
|
|
Last edited
|
12/04/2012
|
|
Date ISRCTN assigned
|
28/02/2001
|
